var data={"title":"Clostridium difficile infection in children: Microbiology, pathogenesis, and epidemiology","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clostridium difficile infection in children: Microbiology, pathogenesis, and epidemiology</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/contributors\" class=\"contributor contributor_credentials\">Jonathan Crews, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/contributors\" class=\"contributor contributor_credentials\">Mary M Torchia, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 21, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Clostridium difficile</em> is an important cause of antibiotic-associated diarrhea and one of the most common health care-associated pathogens [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/1\" class=\"abstract_t\">1</a>]. Its clinical manifestations range from asymptomatic colonization or mild diarrhea to fulminant disease characterized by ileus, toxic megacolon, hypotension, or shock. <em>C. difficile</em> infection is less common in children than adults, but the incidence of <em>C. difficile</em> infection in children is increasing [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2-5\" class=\"abstract_t\">2-5</a>].</p><p>The microbiology, pathogenesis, and epidemiology of <em>C. difficile</em> infection in children will be discussed below. The clinical features, diagnosis, treatment, and prevention of <em>C. difficile</em> infection in children are discussed separately. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Clostridium difficile infection in children: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=clostridium-difficile-infection-in-children-treatment-and-outcome\" class=\"medical medical_review\">&quot;Clostridium difficile infection in children: Treatment and outcome&quot;</a> and <a href=\"topic.htm?path=clostridium-difficile-infection-prevention-and-control\" class=\"medical medical_review\">&quot;Clostridium difficile infection: Prevention and control&quot;</a>.)</p><p><em>C. difficile</em> infection in adults also is discussed separately. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology&quot;</a> and <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-treatment-and-prevention\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Treatment and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MICROBIOLOGY</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Organism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. difficile</em> is an anaerobic, gram-positive, spore-forming, toxin-producing bacillus. It<em> </em>exists in spore form in the environment. The spores are metabolically dormant and resistant to heat, acid, antibiotics, and most disinfectants. After <em>C. difficile</em> spores reach the intestine, they germinate into the vegetative form, which is capable of producing toxins and is susceptible to killing by antimicrobial agents.</p><p><em>C. difficile</em> is widely distributed in nature. It has been found in water, soil, food products, domestic and farm animals, and households [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/6-10\" class=\"abstract_t\">6-10</a>]. Within health care facilities, <em>C. difficile</em> has been cultured from the hands of patients and health care personnel, hospital surfaces, medical equipment, and hospital pet therapy dogs [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/11,12\" class=\"abstract_t\">11,12</a>]. <em>C. difficile</em> can persist on hospital surfaces for months [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Toxins</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Toxins A and B are the major virulence factors of <em>C. difficile</em>. They are encoded by genes (<em>tcdA</em> and <em>tcdB</em>) located on a pathogenicity locus that also contains three regulatory genes. Nontoxigenic strains lack the <em>tcdA</em> and <em>tcdB</em> genes and are nonpathogenic. Toxins A and B mediate disease by disrupting the cytoskeletal structure of intestinal epithelial cells, resulting in inflammation and cell death [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/13\" class=\"abstract_t\">13</a>]. Toxin A (&quot;enterotoxin&quot;) causes inflammation leading to mucosal injury and intestinal fluid secretion [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/14\" class=\"abstract_t\">14</a>]. Toxin B (&quot;cytotoxin&quot;) is essential for the virulence of <em>C. difficile</em> and is more potent than toxin A in mediating colonic mucosal damage [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/15,16\" class=\"abstract_t\">15,16</a>]. Thus, strains lacking toxin A can be as virulent as strains with both toxins [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Fecal toxin levels may correlate with disease severity [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology#H10\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology&quot;, section on 'Toxins'</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Hypervirulent strain (NAP1/BI/027)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A hypervirulent strain of <em>C. difficile</em> <span class=\"nowrap\">(NAP1/BI/027)</span> has been associated with more severe disease, lower cure rates, and increased recurrence rates in adults [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20-22\" class=\"abstract_t\">20-22</a>]. The <span class=\"nowrap\">NAP1/BI/027</span> strain has unique characteristics: It possesses a deletion in the <em>tcdC</em> gene (a negative regulator of toxin production) and produces a third toxin (binary toxin) [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology#H11\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology&quot;, section on 'Hypervirulent strain: NAP1/BI/027'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of <em>C. difficile</em> disease is incompletely understood. However, disease expression is known to involve [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/23,24\" class=\"abstract_t\">23,24</a>] (see <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology#H12\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology&quot;, section on 'Pathophysiology'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alteration of the colonic microbiota (usually, but not always, following antibiotic therapy)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ingestion, colonization, and overgrowth of <em>C. difficile</em></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Production of <em>C. difficile</em> toxin(s) (necessary but not sufficient to cause clinical disease)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Injury to and inflammation of intestinal epithelium</p><p/><p>Other factors may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Production of antibody to toxin A &ndash; Adults with low or undetectable levels of antibody against toxin A are more likely to develop diarrhea than those with detectable antibody [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/25,26\" class=\"abstract_t\">25,26</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Colonization with nontoxigenic strains, which may afford protection against disease from toxigenic <em>C. difficile</em> [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/27,28\" class=\"abstract_t\">27,28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Variable expression of intestinal toxin receptors &ndash; As an example, newborn rabbits lack intestinal receptors for toxin A and are resistant to disease, whereas newborn pigs have receptors and are susceptible to <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/29,30\" class=\"abstract_t\">29,30</a>].</p><p/><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H617615915\"><span class=\"h2\">Incidence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 2011, active population-based surveillance in the United States estimated that the incidence of <em>C. difficile</em> infection in children &lt;18 years was 24.2 cases per 100,000 population (95% CI, 18.7-29.7); approximately two-thirds of cases were community&ndash;associated (no documented overnight stay in a health care facility during the 12 weeks before illness onset) [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/1\" class=\"abstract_t\">1</a>].</p><p>In the early 2000s, an increase in the frequency and severity of <em>C. difficile</em> infection in adults was observed in several hospitals in North America [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20,21\" class=\"abstract_t\">20,21</a>]. These hospital outbreaks were largely attributed to the <span class=\"nowrap\">NAP1/BI/027</span> strain [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20\" class=\"abstract_t\">20</a>]. Since then, the incidence of <em>C. difficile</em> infection has increased considerably. In the United States, the incidence of <em>C. difficile</em>-related hospitalizations more than doubled between 2000 and 2009 [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology#H2\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology&quot;, section on 'Epidemiology'</a>.)</p><p>Increased frequency of <em>C. difficile</em> infection has also been documented for children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2-5\" class=\"abstract_t\">2-5</a>]. For example, among children hospitalized at 22 United States children's hospitals, the incidence of <em>C. difficile</em> infection increased by 53 percent from 2001 to 2006 (2.6 to 4.0 cases per 1000 admissions), a period during which the rate of <em>C. difficile</em> testing remained stable [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2\" class=\"abstract_t\">2</a>]. Similar results were found in a separate national database, with a 57 percent increase in pediatric <em>C. difficile</em>-related hospitalizations between 1997 and 2006 [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/3\" class=\"abstract_t\">3</a>]. A population-based study found a 12.5-fold increase in the incidence of pediatric <em>C. difficile</em> in residents of Olmstead County, Minnesota from 1991 to 1997 to 2004 to 2009 (2.6 to 32.6 per 100,000 persons) [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/32\" class=\"abstract_t\">32</a>]. The highest incidence of <em>C. difficile</em> infection occurs in children one to five years old [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2,3,5\" class=\"abstract_t\">2,3,5</a>].</p><p>The incidence of community-associated <em>C. difficile</em> infection also appears to be increasing [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/32-35\" class=\"abstract_t\">32-35</a>]. The proportion of <em>C. difficile</em> infection in children that is community-associated is unclear given variability in case definition and study design. Population-based studies suggest that 70 to 75 percent of pediatric <em>C. difficile</em> infection is community-associated, while hospital-based studies have produced lower estimates (19 to 41 percent) [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/35-38\" class=\"abstract_t\">35-38</a>]. Children with community-associated infection tend to be healthier and have lower rates of exposure to antibiotics and acid suppressants than children with health care-associated disease [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/37,38\" class=\"abstract_t\">37,38</a>].</p><p class=\"headingAnchor\" id=\"H2310304\"><span class=\"h2\">Severe disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children can experience severe disease and complications from <em>C. difficile</em> infection. Data on the frequency of severe disease in children are limited by the absence of a validated definition. Disease severity is overestimated when adult criteria for severe <em>C. difficile</em> disease are applied to children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/39,40\" class=\"abstract_t\">39,40</a>].</p><p>Studies report that 3 to 7 percent of children with <em>C. difficile</em> develop a fulminant disease &ndash; hypotension or shock, ileus, or toxic megacolon [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/38-41\" class=\"abstract_t\">38-41</a>]. No temporal change in the incidence of colectomy or death has been noted in hospitalized children with <em>C. difficile</em> despite the increased incidence of <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2,4,5\" class=\"abstract_t\">2,4,5</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Colonization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Asymptomatic intestinal colonization with toxigenic <em>C. difficile</em> is common in the neonatal period and infancy [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/42-46\" class=\"abstract_t\">42-46</a>]. This phenomenon has two important implications:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>C. difficile</em> may be an incidental finding in neonates and infants with diarrhea.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neonates and infants may be a reservoir of <em>C. difficile</em>.</p><p/><p class=\"headingAnchor\" id=\"H1876098\"><span class=\"h3\">Neonates and infants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Colonization with toxigenic or nontoxigenic <em>C. difficile</em> is common during the first year of life. Early acquisition during the neonatal period and acquisition later in infancy has been described [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/47\" class=\"abstract_t\">47</a>]. Colonization generally persists for a few months, though it can persist for up to 12 months or longer [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/47,48\" class=\"abstract_t\">47,48</a>]. Shifts between toxigenic and nontoxigenic strains over time have been observed. <em>C. difficile</em> colonization in infants is associated with changes in the infant gut microbiota [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/42\" class=\"abstract_t\">42</a>].</p><p>The rate of colonization reported in the literature varies widely due to differences in the testing method employed and the population studied. In general, colonization with <em>C. difficile</em> can be detected in 25 to 50 percent of neonates (age &lt;28 days) and 40 to 70 percent of infants (age &lt;12 months) [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/43-45,49,50\" class=\"abstract_t\">43-45,49,50</a>].</p><p>The most common source of <em>C. difficile</em> acquisition among hospitalized neonates and infants is the hospital environment, and the risk of colonization increases with the duration of the hospital stay [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/43-45\" class=\"abstract_t\">43-45</a>]. Maternal-infant transmission is only rarely described [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/45,46\" class=\"abstract_t\">45,46</a>]. Various host factors influence <em>C. difficile</em> colonization rates during infancy. Higher rates of colonization are reported in infants who are formula fed (versus breast fed), preterm (versus term), hospitalized, and recently exposed to antibiotics [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/50,51\" class=\"abstract_t\">50,51</a>]. Available data suggest that mode of delivery has little effect on colonization status [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/50\" class=\"abstract_t\">50</a>].</p><p>Although neonates and infants frequently are colonized with toxigenic <em>C. difficile</em>, they rarely develop symptomatic disease [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/43,49,50\" class=\"abstract_t\">43,49,50</a>]. High levels of <em>C. difficile</em> organisms and toxins (levels similar to those in adults with pseudomembranous colitis) can be found in the stools of healthy, asymptomatic neonates and infants [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/44,52\" class=\"abstract_t\">44,52</a>]. The reasons for this paradox are unknown. An absence of intestinal receptors for <em>C. difficile</em> toxins has been proposed. (See <a href=\"#H6\" class=\"local\">'Pathogenesis'</a> above.)</p><p>Neonates and infants may be a reservoir of <em>C. difficile</em> for vulnerable individuals. Toxigenic strains known to circulate in adults have been detected from asymptomatic infants [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/42,47,53\" class=\"abstract_t\">42,47,53</a>]. Additionally, in a case-control study among adults with community-associated diarrhea, individuals with <em>C. difficile</em> infection were more likely to report contact with children &le;2 years old [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/54\" class=\"abstract_t\">54</a>].</p><p class=\"headingAnchor\" id=\"H1876105\"><span class=\"h3\">Children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Beyond infancy, children have lower rates of colonization. By approximately two to three years of age, colonization rates decrease to &lt;5 percent, similar to rates in nonhospitalized adults [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/44,49,50\" class=\"abstract_t\">44,49,50</a>]. Elevated colonization rates have been described among hospitalized children and children with malignancy or inflammatory bowel disease [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/55-57\" class=\"abstract_t\">55-57</a>].</p><p class=\"headingAnchor\" id=\"H2310378\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In health care settings, <em>C. difficile</em> can be spread through human hands, contaminated with <em>C. difficile</em> spores, and through contamination of the health care environment [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/24,58,59\" class=\"abstract_t\">24,58,59</a>]. Factors associated with health care acquisition of <em>C. difficile</em> include ward-level antibiotic use and assignment to a room in which a previous patient had <em>C. difficile</em> [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/24,60\" class=\"abstract_t\">24,60</a>]. Molecular studies suggest that most <em>C. difficile</em> cases at adult hospitals are not linked to a previous symptomatic patient [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/61,62\" class=\"abstract_t\">61,62</a>]. Asymptomatic carriers may be an important source of <em>C. difficile</em> transmission without health care exposure [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/24,62,63\" class=\"abstract_t\">24,62,63</a>].</p><p><em>C. difficile</em> is increasingly acquired in the community by patients without prior health care exposure, antimicrobial treatment, or other established risk factors [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20,33,64\" class=\"abstract_t\">20,33,64</a>]. Asymptomatically colonized neonates and infants may be a source of <em>C. difficile</em> transmission to adults [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/54\" class=\"abstract_t\">54</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Hypervirulent strains</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data regarding the prevalence of infection with hypervirulent strains <span class=\"nowrap\">(NAP1/BI/027)</span> in children are limited. The proportion of pediatric <em>C. difficile</em> stool samples that are the <span class=\"nowrap\">NAP1/BI/027</span> strain has ranged from &lt;1 to 27 percent, as illustrated below:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a prospective study, the <span class=\"nowrap\">NAP1/BI/027</span> strain accounted for approximately 20 percent of 134 consecutive <em>C. difficile</em> toxin-positive stool samples at tertiary care children's hospitals in Cleveland and Philadelphia during 2006-2007 [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/65\" class=\"abstract_t\">65</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In active population-based surveillance from 10 diverse United States locations, the NAP1 strain was identified in 30 of 132 (23 percent) pediatric stool samples that were culture positive for <em>C. difficile</em> during 2010 and 2011 [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/36\" class=\"abstract_t\">36</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a retrospective study, <span class=\"nowrap\">NAP1/BI/027</span> was isolated from only 1 of 117 patients with <em>C. difficile</em> infection at a tertiary care children's hospital in Chicago during 2013 [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/66\" class=\"abstract_t\">66</a>].</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">RISK FACTORS</span></p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Antibiotic exposure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Exposure to antibiotics is the single-most important risk factor for both health care-associated and community-associated <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/24,67-70\" class=\"abstract_t\">24,67-70</a>]. Any antibiotic may predispose to <em>C. difficile</em> infection, though the risk varies across antibiotic classes [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/23,71\" class=\"abstract_t\">23,71</a>]. Cephalosporins, <a href=\"topic.htm?path=clindamycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clindamycin</a>, and fluoroquinolones are most frequently implicated. Sulfonamides, tetracyclines [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/72\" class=\"abstract_t\">72</a>], <a href=\"topic.htm?path=vancomycin-pediatric-drug-information\" class=\"drug drug_pediatric\">vancomycin</a>, <a href=\"topic.htm?path=metronidazole-pediatric-drug-information\" class=\"drug drug_pediatric\">metronidazole</a>, and aminoglycosides are infrequently implicated in children. In pediatric studies, exposure to multiple classes of antibiotics in the preceding 30 days has been associated with severe and recurrent <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/41,73\" class=\"abstract_t\">41,73</a>].</p><p><em>C. difficile</em> infection, including severe disease, can occur in children without prior antibiotics [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/33,34,64,70\" class=\"abstract_t\">33,34,64,70</a>]. In large observational studies, antimicrobial exposure was absent in &gt;40 percent of cases of <em>C. difficile</em> in children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/34,70\" class=\"abstract_t\">34,70</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Other risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Proton pump inhibitors, and to a lesser extent histamine-2 receptor antagonists, have been associated with an increased risk of <em>C. difficile</em> infection in children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/70,74-77\" class=\"abstract_t\">70,74-77</a>]. Gastrointestinal feeding devices (ie, gastrostomy or jejunostomy tubes) have also been associated with <em>C. difficile</em> infection in children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/38,68\" class=\"abstract_t\">38,68</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Predisposing conditions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of medical conditions are associated with <em>C. difficile </em>infection in children.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Malignancy </strong>&ndash; Malignancy is the most common chronic condition among hospitalized children with <em>C. difficile</em> infection, accounting for 20 to 25 percent of hospital-based cases [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2,4,78\" class=\"abstract_t\">2,4,78</a>]. Children with malignancy and <em>C. difficile</em> infection have longer lengths of stay and higher rates of in-hospital mortality compared with children with malignancy without <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/79\" class=\"abstract_t\">79</a>].</p><p/><p class=\"bulletIndent1\">Several factors may predispose pediatric oncology patients to <em>C. difficile</em> infection: repeated exposures to broad-spectrum antibiotics, receipt of chemotherapy, and frequent visits to health care facilities. Variation in the risk of <em>C. difficile</em> infection has been reported across antibiotic classes for pediatric oncology patients [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/79,80\" class=\"abstract_t\">79,80</a>]. As an example, in a multicenter cohort, among antipseudomonal antibiotics, <a href=\"topic.htm?path=cefepime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefepime</a> and <a href=\"topic.htm?path=ceftazidime-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftazidime</a> were independently associated with <em>C. difficile</em> infection, while antipseudomonal penicillins and carbapenems were not [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/80\" class=\"abstract_t\">80</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Transplantation</strong> &ndash; Pediatric hematopoietic and solid organ transplant recipients have an increased risk of <em>C. difficile</em> infection [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/81\" class=\"abstract_t\">81</a>].<strong> </strong><em>C. difficile</em> infection is common following hematopoietic transplantation. In a single-center study, 17 percent of pediatric hematopoietic transplant recipients were diagnosed with <em>C. difficile</em> infection during the 100 days posttransplant [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/82\" class=\"abstract_t\">82</a>]. Among solid organ transplant recipients, the incidence of <em>C. difficile</em> infection varies with the transplanted organ. It is highest with pancreatic and intestinal transplantation and lowest with renal transplantation [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/83\" class=\"abstract_t\">83</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Inflammatory bowel disease</strong><em> &ndash; </em>Children with inflammatory bowel disease (IBD) have a higher rate of symptomatic <em>C. difficile</em> infection and higher rate of recurrence than the general pediatric population [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/84-86\" class=\"abstract_t\">84-86</a>]. Hospitalizations related to <em>C. difficile</em> infection are increasing among children with IBD [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/85\" class=\"abstract_t\">85</a>]. Among children hospitalized with IBD, <em>C. difficile</em> infection is associated with longer stays, increased need for parenteral nutrition, and increased blood transfusions [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/85\" class=\"abstract_t\">85</a>]. <em>C. difficile </em>infection also has been associated with exacerbations of IBD in children [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/84-86\" class=\"abstract_t\">84-86</a>]. (See <a href=\"topic.htm?path=antibiotics-for-treatment-of-inflammatory-bowel-diseases#H15\" class=\"medical medical_review\">&quot;Antibiotics for treatment of inflammatory bowel diseases&quot;, section on 'Clostridium difficile infection'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cystic fibrosis</strong> &ndash; Children with cystic fibrosis may be predisposed to <em>C. difficile</em> infection because of their increased exposure to antibiotics and health care settings. Asymptomatic carriage of toxigenic <em>C. difficile</em> appears to be common in children with cystic fibrosis [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/87\" class=\"abstract_t\">87</a>]. Severe <em>C. difficile</em> infection with typical findings of pseudomembranous colitis has been documented [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/88-91\" class=\"abstract_t\">88-91</a>]. (See <a href=\"topic.htm?path=cystic-fibrosis-overview-of-gastrointestinal-disease#H10\" class=\"medical medical_review\">&quot;Cystic fibrosis: Overview of gastrointestinal disease&quot;, section on 'Distal intestinal obstruction syndrome (DIOS)'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hirschsprung disease</strong> &ndash; Children with Hirschsprung disease may be susceptible to <em>C. difficile</em> infection due to colonic stasis, changes in mucosal defense, and altered colonic flora. While it is not known definitively whether <em>C. difficile</em> contributes to Hirschsprung enterocolitis, the reports of pseudomembranous colitis occurring in infants with Hirschsprung disease suggest the relationship could be causal in some cases [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/92,93\" class=\"abstract_t\">92,93</a>]. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-children-clinical-features-and-diagnosis#H8\" class=\"medical medical_review\">&quot;Clostridium difficile infection in children: Clinical features and diagnosis&quot;, section on 'Pseudomembranous colitis'</a> and <a href=\"topic.htm?path=emergency-complications-of-hirschsprung-disease#H5\" class=\"medical medical_review\">&quot;Emergency complications of Hirschsprung disease&quot;, section on 'Enterocolitis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Structural or postoperative intestinal disorders</strong> &ndash; Severe <em>C. difficile</em> disease may occur in children with structural intestinal disorders and after intestinal operations, including placement of an ileostomy. Severe enteritis should prompt consideration of <em>C. difficile</em> disease in such children, in the immediate postoperative period and any time thereafter [<a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/94,95\" class=\"abstract_t\">94,95</a>].</p><p/><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Clostridium difficile</em> is an anaerobic, gram-positive, spore-forming, toxin-producing bacillus. The spore form of <em>C. difficile</em> is resistant to heat, acid, antibiotics, and most disinfectants, and can persist in the hospital environment for several months. (See <a href=\"#H3\" class=\"local\">'Organism'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pathogenesis of <em>C. difficile</em> disease involves altered colonic microflora; <em>C. difficile</em> ingestion, colonization, and overgrowth; toxin production; and toxin injury of intestinal epithelial cells, resulting in inflammation and diarrhea. (See <a href=\"#H6\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymptomatic <em>C. difficile</em> colonization is common among neonates and infants; reported rates range up to 50 percent in neonates and 70 percent of infants younger than one year. Given the high frequency of asymptomatic colonization, <em>C. difficile</em> may be an incidental finding in neonates and infants with diarrhea. (See <a href=\"#H11\" class=\"local\">'Colonization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antibiotic use is the most important risk factor for <em>C. difficile</em> infection in children. The antibiotics most frequently implicated include <a href=\"topic.htm?path=clindamycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clindamycin</a>, cephalosporins, and fluoroquinolones. A minority of cases occur without prior antimicrobial exposure. (See <a href=\"#H14\" class=\"local\">'Antibiotic exposure'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Additional risk factors for <em>C. difficile</em> infection in children include gastric acid suppressants and gastrointestinal feeding devices. (See <a href=\"#H15\" class=\"local\">'Other risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Certain medical conditions may predispose to <em>C. difficile</em> infection, may increase the risk of severe <em>C. difficile</em> infection, or may be exacerbated by <em>C. difficile</em> infection. These include malignancy, hematopoietic cell or solid organ transplantation, inflammatory bowel disease, cystic fibrosis, and Hirschsprung disease. (See <a href=\"#H16\" class=\"local\">'Predisposing conditions'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Michael Cooperstock, MD, MPH, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/1\" class=\"nounderline abstract_t\">Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:825.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/2\" class=\"nounderline abstract_t\">Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122:1266.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/3\" class=\"nounderline abstract_t\">Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/4\" class=\"nounderline abstract_t\">Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165:451.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/5\" class=\"nounderline abstract_t\">Deshpande A, Pant C, Anderson MP, et al. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr Infect Dis J 2013; 32:1138.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/6\" class=\"nounderline abstract_t\">Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 2007; 13:485.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/7\" class=\"nounderline abstract_t\">Bauer MP, Kuijper EJ. Potential sources of Clostridium difficile in human infection. Infect Dis Clin North Am 2015; 29:29.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/8\" class=\"nounderline abstract_t\">Bakri MM, Brown DJ, Butcher JP, Sutherland AD. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis 2009; 15:817.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/9\" class=\"nounderline abstract_t\">Koene MG, Mevius D, Wagenaar JA, et al. Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect 2012; 18:778.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/10\" class=\"nounderline abstract_t\">Alam MJ, Anu A, Walk ST, Garey KW. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe 2014; 27:31.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/11\" class=\"nounderline abstract_t\">Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/12\" class=\"nounderline abstract_t\">Lefebvre SL, Weese JS. Contamination of pet therapy dogs with MRSA and Clostridium difficile. J Hosp Infect 2009; 72:268.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/13\" class=\"nounderline abstract_t\">Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/14\" class=\"nounderline abstract_t\">Lima AA, Innes DJ Jr, Chadee K, et al. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine. Lab Invest 1989; 61:419.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/15\" class=\"nounderline abstract_t\">Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95:2004.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/16\" class=\"nounderline abstract_t\">Lyras D, O'Connor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458:1176.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/17\" class=\"nounderline abstract_t\">Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2706.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/18\" class=\"nounderline abstract_t\">Drudy D, Fanning S, Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis 2007; 11:5.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/19\" class=\"nounderline abstract_t\">Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/20\" class=\"nounderline abstract_t\">McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/21\" class=\"nounderline abstract_t\">Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/22\" class=\"nounderline abstract_t\">Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55:351.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/23\" class=\"nounderline abstract_t\">Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372:1539.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/24\" class=\"nounderline abstract_t\">Caroff DA, Yokoe DS, Klompas M. Evolving insights into the epidemiology and control of Clostridium difficile in hospitals. Clin Infect Dis 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/25\" class=\"nounderline abstract_t\">Leung DY, Kelly CP, Boguniewicz M, et al. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118:633.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/26\" class=\"nounderline abstract_t\">Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342:390.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/27\" class=\"nounderline abstract_t\">Gerding DN, Meyer T, Lee C, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015; 313:1719.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/28\" class=\"nounderline abstract_t\">Shim JK, Johnson S, Samore MH, et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351:633.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/29\" class=\"nounderline abstract_t\">Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest 1992; 90:822.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/30\" class=\"nounderline abstract_t\">Keel MK, Songer JG. The distribution and density of Clostridium difficile toxin receptors on the intestinal mucosa of neonatal pigs. Vet Pathol 2007; 44:814.</a></li><li class=\"breakAll\">Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in Hospital Stays, 2009. HCUP Statistical Brief #124. January 2012. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf (Accessed on August 10, 2015).</li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/32\" class=\"nounderline abstract_t\">Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013; 56:1401.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/33\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:340.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/34\" class=\"nounderline abstract_t\">Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007; 28:1233.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/35\" class=\"nounderline abstract_t\">McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/36\" class=\"nounderline abstract_t\">Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014; 133:651.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/37\" class=\"nounderline abstract_t\">Tschudin-Sutter S, Tamma PD, Naegeli AN, et al. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis 2013; 57:1665.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/38\" class=\"nounderline abstract_t\">Crews JD, Koo HL, Jiang ZD, et al. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J 2014; 33:924.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/39\" class=\"nounderline abstract_t\">Pai S, Aliyu SH, Enoch DA, Karas JA. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 2012; 7:e51728.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/40\" class=\"nounderline abstract_t\">Tschudin-Sutter S, Tamma PD, Milstone AM, Perl TM. The prediction of complicated Clostridium difficile infections in children. Infect Control Hosp Epidemiol 2014; 35:901.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/41\" class=\"nounderline abstract_t\">Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31:134.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/42\" class=\"nounderline abstract_t\">Rousseau C, Lem&eacute;e L, Le Monnier A, et al. Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 2011; 60:1112.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/43\" class=\"nounderline abstract_t\">Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146:727.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/44\" class=\"nounderline abstract_t\">Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81:5.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/45\" class=\"nounderline abstract_t\">Al-Jumaili IJ, Shibley M, Lishman AH, Record CO. Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol 1984; 19:77.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/46\" class=\"nounderline abstract_t\">Martirosian G, Kuipers S, Verbrugh H, et al. PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol 1995; 33:2016.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/47\" class=\"nounderline abstract_t\">Rousseau C, Poilane I, De Pontual L, et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012; 55:1209.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/48\" class=\"nounderline abstract_t\">Adlerberth I, Huang H, Lindberg E, et al. Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants. J Clin Microbiol 2014; 52:173.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/49\" class=\"nounderline abstract_t\">Holst E, Helin I, M&aring;rdh PA. Recovery of Clostridium difficile from children. Scand J Infect Dis 1981; 13:41.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/50\" class=\"nounderline abstract_t\">Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51:2.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/51\" class=\"nounderline abstract_t\">Cooperstock M, Riegle L, Woodruff CW, Onderdonk A. Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile. J Clin Microbiol 1983; 17:830.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/52\" class=\"nounderline abstract_t\">Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 1982; 35:895.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/53\" class=\"nounderline abstract_t\">Stoesser N, Crook DW, Fung R, et al. Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection. J Clin Microbiol 2011; 49:3994.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/54\" class=\"nounderline abstract_t\">Wilcox MH, Mooney L, Bendall R, et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62:388.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/55\" class=\"nounderline abstract_t\">Leibowitz J, Soma VL, Rosen L, et al. Similar proportions of stool specimens from hospitalized children with and without diarrhea test positive for Clostridium difficile. Pediatr Infect Dis J 2015; 34:261.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/56\" class=\"nounderline abstract_t\">Burgner D, Siarakas S, Eagles G, et al. A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients. Pediatr Infect Dis J 1997; 16:1131.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/57\" class=\"nounderline abstract_t\">Hourigan SK, Chirumamilla SR, Ross T, et al. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19:2744.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/58\" class=\"nounderline abstract_t\">Samore MH, Venkataraman L, DeGirolami PC, et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/59\" class=\"nounderline abstract_t\">Bobulsky GS, Al-Nassir WN, Riggs MM, et al. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008; 46:447.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/60\" class=\"nounderline abstract_t\">Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32:201.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/61\" class=\"nounderline abstract_t\">Curry SR, Muto CA, Schlackman JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013; 57:1094.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/62\" class=\"nounderline abstract_t\">Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013; 369:1195.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/63\" class=\"nounderline abstract_t\">Clabots CR, Johnson S, Olson MM, et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:561.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/64\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/65\" class=\"nounderline abstract_t\">Toltzis P, Kim J, Dul M, et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 2009; 154:607.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/66\" class=\"nounderline abstract_t\">Kociolek LK, Patel SJ, Shulman ST, Gerding DN. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol 2015; 36:445.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/67\" class=\"nounderline abstract_t\">Deshpande A, Pasupuleti V, Thota P, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68:1951.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/68\" class=\"nounderline abstract_t\">Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011; 30:580.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/69\" class=\"nounderline abstract_t\">Tamma PD, Sandora TJ. Clostridium difficile Infection in Children: Current State and Unanswered Questions. J Pediatric Infect Dis Soc 2012; 1:230.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/70\" class=\"nounderline abstract_t\">Adams DJ, Eberly MD, Rajnik M, Nylund CM. Risk Factors for Community-Associated Clostridium difficile Infection in Children. J Pediatr 2017; 186:105.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/71\" class=\"nounderline abstract_t\">Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46 Suppl 1:S19.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/72\" class=\"nounderline abstract_t\">Tariq R, Cho J, Kapoor S, et al. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Clin Infect Dis 2018; 66:514.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/73\" class=\"nounderline abstract_t\">Nicholson MR, Thomsen IP, Slaughter JC, et al. Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 2015; 60:18.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/74\" class=\"nounderline abstract_t\">Turco R, Martinelli M, Miele E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010; 31:754.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/75\" class=\"nounderline abstract_t\">Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107:1001.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/76\" class=\"nounderline abstract_t\">Nylund CM, Eide M, Gorman GH. Association of Clostridium difficile infections with acid suppression medications in children. J Pediatr 2014; 165:979.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/77\" class=\"nounderline abstract_t\">Freedberg DE, Lamous&eacute;-Smith ES, Lightdale JR, et al. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Clin Infect Dis 2015; 61:912.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/78\" class=\"nounderline abstract_t\">Tai E, Richardson LC, Townsend J, et al. Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 2011; 30:610.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/79\" class=\"nounderline abstract_t\">de Blank P, Zaoutis T, Fisher B, et al. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013; 163:699.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/80\" class=\"nounderline abstract_t\">Fisher BT, Sammons JS, Li Y, et al. Variation in Risk of Hospital-Onset Clostridium difficile Infection Across &beta;-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. J Pediatric Infect Dis Soc 2014; 3:329.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/81\" class=\"nounderline abstract_t\">Nicholson MR, Osgood CL, Acra SA, Edwards KM. Clostridium difficile infection in the pediatric transplant patient. Pediatr Transplant 2015; 19:792.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/82\" class=\"nounderline abstract_t\">Boyle NM, Magaret A, Stednick Z, et al. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control 2015; 4:41.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/83\" class=\"nounderline abstract_t\">Pant C, Deshpande A, Desai M, et al. Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients. Transpl Infect Dis 2016; 18:31.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/84\" class=\"nounderline abstract_t\">Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009; 154:854.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/85\" class=\"nounderline abstract_t\">Sandberg KC, Davis MM, Gebremariam A, Adler J. Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011. J Pediatr Gastroenterol Nutr 2015; 60:486.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/86\" class=\"nounderline abstract_t\">Martinelli M, Strisciuglio C, Veres G, et al. Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014; 20:2219.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/87\" class=\"nounderline abstract_t\">Yahav J, Samra Z, Blau H, et al. Helicobacter pylori and Clostridium difficile in cystic fibrosis patients. Dig Dis Sci 2006; 51:2274.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/88\" class=\"nounderline abstract_t\">Rivlin J, Lerner A, Augarten A, et al. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr 1998; 132:177.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/89\" class=\"nounderline abstract_t\">Hussain SZ, Chu C, Greenberg DP, et al. Clostridium difficile colitis in children with cystic fibrosis. Dig Dis Sci 2004; 49:116.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/90\" class=\"nounderline abstract_t\">Yates B, Murphy DM, Fisher AJ, et al. Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation. Thorax 2007; 62:554.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/91\" class=\"nounderline abstract_t\">Theunissen C, Knoop C, Nonhoff C, et al. Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation. Transpl Infect Dis 2008; 10:240.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/92\" class=\"nounderline abstract_t\">Urushihara N, Kohno S, Hasegawa S. Pseudomembranous enterocolitis and hemorrhagic necrotizing enterocolitis in Hirschsprung's disease. Surg Today 1994; 24:221.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/93\" class=\"nounderline abstract_t\">Mc Laughlin D, Friedmacher F, Puri P. The impact of Clostridium difficile on paediatric surgical practice: a systematic review. Pediatr Surg Int 2014; 30:853.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/94\" class=\"nounderline abstract_t\">Williams RN, Hemingway D, Miller AS. Enteral Clostridium difficile, an emerging cause for high-output ileostomy. J Clin Pathol 2009; 62:951.</a></li><li><a href=\"https://www.uptodate.com/contents/clostridium-difficile-infection-in-children-microbiology-pathogenesis-and-epidemiology/abstract/95\" class=\"nounderline abstract_t\">Causey MW, Spencer MP, Steele SR. Clostridium difficile enteritis after colectomy. Am Surg 2009; 75:1203.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6041 Version 28.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H20\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MICROBIOLOGY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Organism</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Toxins</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Hypervirulent strain (NAP1/BI/027)</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">PATHOGENESIS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">EPIDEMIOLOGY</a><ul><li><a href=\"#H617615915\" id=\"outline-link-H617615915\">Incidence</a></li><li><a href=\"#H2310304\" id=\"outline-link-H2310304\">Severe disease</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Colonization</a><ul><li><a href=\"#H1876098\" id=\"outline-link-H1876098\">- Neonates and infants</a></li><li><a href=\"#H1876105\" id=\"outline-link-H1876105\">- Children</a></li></ul></li><li><a href=\"#H2310378\" id=\"outline-link-H2310378\">Transmission</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Hypervirulent strains</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">RISK FACTORS</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">Antibiotic exposure</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Other risk factors</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Predisposing conditions</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">SUMMARY</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antibiotics-for-treatment-of-inflammatory-bowel-diseases\" class=\"medical medical_review\">Antibiotics for treatment of inflammatory bowel diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Clostridium difficile infection in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology\" class=\"medical medical_review\">Clostridium difficile infection in adults: Epidemiology, microbiology, and pathophysiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-treatment-and-prevention\" class=\"medical medical_review\">Clostridium difficile infection in adults: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Clostridium difficile infection in children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-children-treatment-and-outcome\" class=\"medical medical_review\">Clostridium difficile infection in children: Treatment and outcome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-prevention-and-control\" class=\"medical medical_review\">Clostridium difficile infection: Prevention and control</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cystic-fibrosis-overview-of-gastrointestinal-disease\" class=\"medical medical_review\">Cystic fibrosis: Overview of gastrointestinal disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=emergency-complications-of-hirschsprung-disease\" class=\"medical medical_review\">Emergency complications of Hirschsprung disease</a></li></ul></div></div>","javascript":null}